Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas

British Journal of Cancer

Volumn 74, Issue 10, 1996, Pages 1592-1597

  Papp, J ^a   Csokay, B ^a   Bosze, P ^a   Zalay, Z ^a   Toth, J ^a   Ponder, B ^b   Olah, E ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

BRCA1; c erbB 2; Chromosome 17; Loss of heterozygosity; Ovarian carcinoma; p53

Indexed keywords

DNA MARKER;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER GENETICS; CANCER STAGING; CHROMOSOME 17; CHROMOSOME 17P; CHROMOSOME 17Q; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATION RATE; ONCOGENE NEU; OVARY CARCINOMA; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0029854803     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.594     Document Type: Article

References (38)

1. CLIBY W, RITLAND S, HARTMANN L, DODSON M, HALLING KC, KEENEY G, PODRATZ KC AND JENKINS RB. (1993). Allelotype of ovarian cancer. Cancer Res., 53, 2393-2398.
2. COLES C, THOMPSON AM, ELDER PA, COHEN BB, MACKENZIE IM, CRANSTON G, CHETTY U, MACKAY J, MACDONALD M, NAKAMURA Y, HOYHEIM B AND STEEL CM. (1990). Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet, 336, 761-763.
3. CORNELIS RS, NEUHAUSEN SL, JOHANSSON O, ARASON A, KELSELL D, PONDER BAJ, TONIN P, HAMANN U, LINDBLOM A, LALLE P, LONGY M, OLÁH E, SCHERNECK S, BIGNON Y-J, SOBOL H, CHANG-CLAUDE J, LARSSON C, SPURR N, BORG A, BARKARDOTTIR RB, NAROD S, DEVILEE P AND THE BREAST CANCER LINKAGE CONSORTIUM. (1995). High allele loss rates at 17q12 q21 in breast and ovarian tumors from BRCA1-linked families. Genes Chrom. Cancer, 13, 203-210.
4. DEVILLE P AND CORNELISSE CJ. (1994). Somatic genetic changes in human breast cancer. Biochim. Biophys. Acta, 1198, 113-130.
5. ECCLES DM, CRANSTON G, STEEL CM, NAKAMURA Y AND LEONARD RCF. (1990). Allele losses on chromosome 17 in human epithelial ovarian carcinoma. Oncogene, 5, 1599-1601.
6. ECCLES DM, BRETT L, LESSELLS A, GRUBER A, LANE D, STEEL CM AND LEONARD RCF. (1992a). Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma. Br. J. Cancer, 65, 40-44.
7. ECCLES DM, RUSSELL SEH, HAITES NE AND THE ABE OVARIAN CANCER GENETICS GROUP. (1992b). Early loss of heterozygosity on 17q in ovarian cancer. Oncogene, 7, 2069-2072.
8. FOULKES WD, BLACK DM, STAMI GWH, SOLOMON E AND TROWSDALE J. (1991). Allele loss on chromosome 17 in sporadic ovarian cancer. Lancet, 338, 444-445.
9. FOULKES WD, BLACK DM, STAMI GWH, SOLOMON E AND TROWSDALE J. (1993). Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int. J. Cancer, 54, 220-225.
10. FUTREAL PA, LIU Q, SHATTUCK-EIDENS D, COCHRAN C, HARSHMAN K, TAVTIGIAN S, BENNETT LM, HAUGEN-STRANO A, SWENSEN J, MIKI Y, EDDINGTON K, MCCLURE M, FRYE C, WEAVER-FELDHAUS J, DING W, GHOLAMI Z, SÖDERKVIST P, TERRY L, JHAWAR S, BERCHUCK A, IGLAHART JD, MARKS J, BALLINGER DG, BARRETT JC, SKOLNICK MH, KAMB A AND WISEMAN R. (1994). BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120-122.
11. GODWIN AK, VENDERVEER L, SCHULTZ DC, LYNCH HT, ALTOMARE DA, BUETOW KH, DALY M, GETTS LA, MASNY A, ROSENBLUM N, HOGAN M, OZOLS RF AND HAMILTON TC. (1994). A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. Am. J. Hum. Genet., 55, 666-677.
12. GREENBLATT MS, BENNETT WP, HOLLSTEIN M AND HARRIS CC. (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molelcular pathogenesis. Cancer Res., 54, 4855-4878.
13. HALL JM, LEE MK, NEWMAN B, MORROW JE, ANDERSON LA, HUEY B AND KING M-C. (1990). Linkage of early-onset familial breast cancer to chromosome 17q21. Science, 250, 1684-1689.
14. HALL JM, FRIEDMAN L, GUENTHER C, LEE MK, WEBER JL, BLACK DM AND KING M-C. (1992). Closing in on a breast cancer gene on chromosome 17q. Am. J. Hum. Genet., 50, 1235-1242.
15. HASTIE ND, DEMPSTER M, DUNLOP MG, THOMPSON AM, GREEN DK AND ALLSHIRE RC. (1990). Telomere reduction in human colorectal carcinoma and with ageing. Nature, 346, 866-868.
16. HOLT JT, THOMPSON ME, SZABO C, ROBINSON-BENION C, ARTEAGA CL, KING M-C AND JENSEN RA. (1996). Growth retardation and tumour inhibition by BRCA1. Nature Genet., 12, 298-302.
17. JACOBS IJ, SMITH SA, WISEMAN RW, FUTREAL PA, HARRINGTON T, OSBORNE RJ, LEECH V, MOLYNEUX A, BERCHUCK A, PONDER BAJ AND BAST RC JR. (1993). A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus. Cancer Res., 53, 1218-1221.
18. JONES MH AND NAKAMURA Y. (1992). Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chrom. Cancer, 5, 89-90.
19. KOHLER MF, MARKS JR, WISEMAN RW, JACOBS IJ, DAVIDOFF AM, CLARKE-PEARSON DL, SOPER JT, BASZ RC JR AND BERCHUCK A. (1993). Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer. J. Natl Cancer Inst., 85, 1513-1519.
20. LEE JH, KAVANAGH JJ, WILDRICK DM, WHARTON JT AND BLICK M. (1990). Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res., 50, 2724-2728.
21. LINDBLOM A, SKOOG L, ANDERSEN TI, ROTSTEIN S, NORDENSKJÖLD M AND LARSSON C. (1993). Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas. Hum. Genet., 91, 6-12.
22. MERAJVER SD, PHAM TM, CADUFF RF, CHEN M, POY EL, COONEY KA, WEBER BL, COLINS FS, JOHNSTON C AND FRANK TS. (1995). Somatic mutations in the BRCA1 gene in sporadic ovarian tumors. Nature Genet., 9, 439-443.
23. MIKI Y, SWENSEN J, SHATTUCK-EIDENS D, FUTREAL PA, HARSHMAN K, TAVTIGIAN S, LIU Q, COCHRAN C, BENNETT LM, DING W, BELL R, ROSENTHAL J, HUSSEY C, TRAN T, McCLURE M, FRYE C, HATTIER T, PHELPS R, HAUGEN-STRANO A, KATCHER H, YAKUMO K, GHOLAMI Z, SHAFFER D, STONE S, BAYER S, WRAY C, BOGDEN R, DAYANANTH P, WARD J, TONIN P, NAROD S, BRISTOW PK, NORRIS FH, HELVERING L, MORRISON P, ROSTECK P, LAI M, BARRETT JC, LEWIS C, NEUHAUSEN S, CANNON-ALBRIGHT L, GOLDGAR D, WISEMAN R, KAMB A AND SKOLNICK MH. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
24. MILLNER BJ, ALLAN LA, ECCLES DM, KITCHENER HC, LEONARD RCF, KELLY KF, PARKIN DE AND HAITES NE. (1993). p53 mutation is a common genetic event in ovarian carcinoma. Cancer Res., 53, 2128-2132.
25. NAROD S, FEUNTEUN J, LYNCH HT, WATSON P, CONWAY T, LYNCH J AND LENOIR GM. (1991). Familial breast-ovarian cancer locus on chromosome 17q12-23. Lancet, 338, 82-83.
26. OKAMOTO A, SAMESHIMA Y, YOKOYAMA S, TERASHIMA Y, SUGIMARA T, TERADA M AND YOKOTA J. (1991). Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res., 51, 5171-5176.
27. PHILLIPS N, ZIEGLER M, SAHA B AND XYNOS F. (1993). Allelic loss on chromosome 17 in human ovarian cancer. Int. J. Cancer, 54, 85-91.
28. PIERETTI M, POWEL DE, GALLION HH, CASE EA, CONWAY PS AND TURKER MS. (1995). Genetic alterations on chromosome 17 distinguish different types of epithelial ovarian tumors. Hum. Pathol., 26, 393-397.
29. RUSSELL SEH, HICKEY GI, LOWRY WS, WHITE P AND ATKINSON RJ. (1990). Allele loss from chromosome 17 in ovarian cancer. Oncogene, 5, 1581-1583.
30. SAITO H, INAZAWA J, SAITO S, KASUMI F, KOI S, SAGAE S, KUDO R, SAITO J, NODA K AND NAKAMURA Y. (1993). Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res., 53, 3382-3385.
31. SAITO S, SAITO H, KOI S, SAGAE S, KUDO R, SAITO J, NODA K AND NAKAMURA Y. (1992). Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers. Cancer Res., 52, 5815-5817.
32. SLAMON DJ, GODOLPHIN W, JONES LA, HOLT J, WONG SG, KEITH DK, LEVIN WJ, STUART SG, UDOVE J, ULLRICH A AND PRESS MF. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712.
33. STACK M, JONES D, WHITE G, LISCIA DS, VENESIO T, CASEY G, CRICHTON D, VARLEY J, MITCHELL E, HEIGHWAY J AND SANTIBANEZ-KOREF M. (1995). Detailed mapping and loss of heterozygosity analysis suggests a suppressor locus involved in sporadic breast cancer within a distal region of chromosome band 17p13.3. Hum. Mol. Genet., 4, 2047-2055.
34. TAVASSOLI M, RUHRBERG C, BEAUMONT V, REYNOLDS K, KIRKHAM N, COLLINS WP AND FARZANEH F. (1993). Whole chromosome 17 loss in ovarian cancer. Genes Chrom. Cancer, 8, 195-198.
35. TSAO SW, MOK CH, OIKE K, MUTO M, GOODMAN HM, SHEETS EE, BERKOWITZ RS, KNAPP RC AND LAU CC. (1991). Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors. Anticancer Res., 11, 1975-1982.
36. WALES MM, BIEL MA, ELDEIRY W, NELKIN BD, ISSA P, CAVENEE WK, KUERBITZ SJ AND BAYLIN SB. (1995). p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med., 1, 570-577.
37. WAN M, ZWEIZIG S, D'ABLAING G, ZHENG J, VELICESCU M AND DUBEAU L. (1994). Three distinct regions of chromosome 6 are targets of loss of heterozygosity in human ovarian carcinomas. Int. J. Oncol., 5, 1043-1048.
38. YANG-FENG TL, HAN H, CHEN K-C, LI S, CLAUS EB, CARCANGIU ML, CHAMBERS SK, CHAMBERS JT AND SCHWARTZ PE. (1993). Allelic loss in ovarian cancer. Int. J. Cancer, 54, 546-551.